![](https://www.pharmaplan.com/wp-content/uploads/2021/11/rauten_header_oben.png)
Our
references
Comprehensive Expertise in One Place
We design and develop a wide range of facilities and site infrastructure for the pharmaceutical and biotech industries. Our extensive portfolio includes facilities for research, development, production, and warehousing. Pharmaplan serves clients as a general design contractor or EPCMV partner, and our in-house teams of experienced architects, engineers, and scientists are equipped to cover all relevant project disciplines.
Agroscope / Savida AG
Switzerland
ongoing
Pharmaplan worked with Savida to design and realize analytical laboratories for biological, biochemical, and chemical working methods in biosafety levels 2 and 3 as well as work with radioactive substances type C.
CARBOGEN AMCIS
France
2023
As EPCMV partner, Pharmaplan developed the entire design of a new injectables facility, adapted to handle high potent products, and is now supporting CARBOGEN AMCIS for the execution step. We will accompany our customer up to qualification and handover activities.
F. Hoffmann-La Roche AG
Switzerland
2024
The new pRED (Pharma Research and Early Development) innovation center, will be the hub of Roche`s research activities in Basel.
CSL Behring AG
Switzerland
2021
With Pharmaplan as lead consultant and EPCMV partner, CSL Behring is expanding its production capacity to keep up with global demand for its market leading immunoglobulin products.
Boehringer Ingelheim Pharma GmbH & Co. KG
Germany
2021
Boehringer Ingelheim’s new launch facility covers containment OEB4 requirements and a design for easy implementation of new manufacturing technologies in the future.
DSP SAS, Groupe DuPont
France
2021
As EPCMV partner, Pharmaplan conducted the complete basic design, detailed design, construction and qualification of a building extension with a new fluid bed dryer for ionic exchange resin production.
Boehringer Ingelheim Animal Health
France
2021
As EPCMV partner, Pharmaplan conducted the complete detailed design, construction and qualification of a new facility for formulation and filling of inactivated virus vaccines for farm animals.